...
search icon
pacb-img

Pacific Biosciences of California, Common Stock

PACB

NSQ

$1.61

-$0.06

(-3.59%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$446.37M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
6.32M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.01
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.16 L
$7.09 H
$1.61

About Pacific Biosciences of California, Common Stock

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FramePACBSectorS&P500
1-Week Return-5.29%3.54%-0.58%
1-Month Return-10.06%7.51%1.89%
3-Month Return-12.5%-0.85%3.24%
6-Month Return-21.46%-1.67%10.09%
1-Year Return-78.24%5.2%22.09%
3-Year Return-84%13.08%35.68%
5-Year Return-66.32%44.4%83.47%
10-Year Return-79.85%111.45%200.41%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue90.89M78.89M130.51M128.30M200.52M[{"date":"2019-12-31","value":45.33,"profit":true},{"date":"2020-12-31","value":39.34,"profit":true},{"date":"2021-12-31","value":65.09,"profit":true},{"date":"2022-12-31","value":63.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue56.31M46.33M71.65M79.27M147.74M[{"date":"2019-12-31","value":38.12,"profit":true},{"date":"2020-12-31","value":31.36,"profit":true},{"date":"2021-12-31","value":48.5,"profit":true},{"date":"2022-12-31","value":53.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit34.58M32.57M58.86M49.03M52.78M[{"date":"2019-12-31","value":58.74,"profit":true},{"date":"2020-12-31","value":55.33,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":83.31,"profit":true},{"date":"2023-12-31","value":89.67,"profit":true}]
Gross Margin38.04%41.28%45.10%38.22%26.32%[{"date":"2019-12-31","value":84.35,"profit":true},{"date":"2020-12-31","value":91.53,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.74,"profit":true},{"date":"2023-12-31","value":58.36,"profit":true}]
Operating Expenses135.12M136.95M237.02M353.85M387.25M[{"date":"2019-12-31","value":34.89,"profit":true},{"date":"2020-12-31","value":35.37,"profit":true},{"date":"2021-12-31","value":61.21,"profit":true},{"date":"2022-12-31","value":91.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(100.55M)(104.39M)(178.16M)(304.82M)(334.47M)[{"date":"2019-12-31","value":-10054500000,"profit":false},{"date":"2020-12-31","value":-10438500000,"profit":false},{"date":"2021-12-31","value":-17816300000,"profit":false},{"date":"2022-12-31","value":-30481900000,"profit":false},{"date":"2023-12-31","value":-33446700000,"profit":false}]
Total Non-Operating Income/Expense13.80M133.52M(109.24M)(24.12M)1.89M[{"date":"2019-12-31","value":10.34,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-81.81,"profit":false},{"date":"2022-12-31","value":-18.06,"profit":false},{"date":"2023-12-31","value":1.41,"profit":true}]
Pre-Tax Income(84.13M)29.40M(274.87M)(314.25M)(318.16M)[{"date":"2019-12-31","value":-286.14,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-934.84,"profit":false},{"date":"2022-12-31","value":-1068.76,"profit":false},{"date":"2023-12-31","value":-1082.06,"profit":false}]
Income Taxes(6.32M)(6.98M)(93.65M)(17.32M)(11.42M)[{"date":"2019-12-31","value":-631500000,"profit":false},{"date":"2020-12-31","value":-698200000,"profit":false},{"date":"2021-12-31","value":-9364900000,"profit":false},{"date":"2022-12-31","value":-1731800000,"profit":false},{"date":"2023-12-31","value":-1142400000,"profit":false}]
Income After Taxes(77.82M)36.38M(181.22M)(296.93M)(306.74M)[{"date":"2019-12-31","value":-213.88,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-498.07,"profit":false},{"date":"2022-12-31","value":-816.08,"profit":false},{"date":"2023-12-31","value":-843.03,"profit":false}]
Income From Continuous Operations(102.13M)(102.60M)(181.22M)(314.25M)(309.10M)[{"date":"2019-12-31","value":-10213400000,"profit":false},{"date":"2020-12-31","value":-10259700000,"profit":false},{"date":"2021-12-31","value":-18122300000,"profit":false},{"date":"2022-12-31","value":-31424800000,"profit":false},{"date":"2023-12-31","value":-30910100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(77.82M)29.40M(181.22M)(296.93M)(306.74M)[{"date":"2019-12-31","value":-264.66,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-616.34,"profit":false},{"date":"2022-12-31","value":-1009.86,"profit":false},{"date":"2023-12-31","value":-1043.21,"profit":false}]
EPS (Diluted)(0.66)(0.13)(1.20)(1.40)(1.21)[{"date":"2019-12-31","value":-66.03,"profit":false},{"date":"2020-12-31","value":-13,"profit":false},{"date":"2021-12-31","value":-120,"profit":false},{"date":"2022-12-31","value":-140,"profit":false},{"date":"2023-12-31","value":-121,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PACB
Cash Ratio 7.85
Current Ratio 9.74
Quick Ratio 8.64

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PACB
ROA (LTM) -10.61%
ROE (LTM) -64.80%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PACB
Debt Ratio Lower is generally better. Negative is bad. 0.69
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.31

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PACB
Trailing PE NM
Forward PE NM
P/S (TTM) 2.84
P/B 1.10
Price/FCF NM
EV/R 5.47
EV/Ebitda NM
PEG NM

FAQs

What is Pacific Biosciences of California share price today?

Pacific Biosciences of California (PACB) share price today is $1.61

Can Indians buy Pacific Biosciences of California shares?

Yes, Indians can buy shares of Pacific Biosciences of California (PACB) on Vested. To buy Pacific Biosciences of California from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PACB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Pacific Biosciences of California be purchased?

Yes, you can purchase fractional shares of Pacific Biosciences of California (PACB) via the Vested app. You can start investing in Pacific Biosciences of California (PACB) with a minimum investment of $1.

How to invest in Pacific Biosciences of California shares from India?

You can invest in shares of Pacific Biosciences of California (PACB) via Vested in three simple steps:

  • Click on Sign Up or Invest in PACB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Pacific Biosciences of California shares
What is Pacific Biosciences of California 52-week high and low stock price?

The 52-week high price of Pacific Biosciences of California (PACB) is $7.09. The 52-week low price of Pacific Biosciences of California (PACB) is $1.16.

What is Pacific Biosciences of California price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Pacific Biosciences of California (PACB) is 1.10

What is the Market Cap of Pacific Biosciences of California?

The market capitalization of Pacific Biosciences of California (PACB) is $446.37M

What is Pacific Biosciences of California’s stock symbol?

The stock symbol (or ticker) of Pacific Biosciences of California is PACB

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top